glp 1 wonder drug Dr. Stephanie's GLP-1 Wonder, 30 CT Until now, they were largely

T2D is a strong independent risk factor for the development of HF, which is one of its earliest and most common cardiovascular complications

We still don't know for sure about the long-term effects of GLP-1 use, said Dr

doi: 10.3389/FPHAR.2025.1517272/FULL 129 BonfioliGBRodellaLMetraMVizzardiE

Asia Pacific Expected to Record the Highest CAGR The Asia Pacific region is projected to register the fastest CAGR during the forecast period, driven by the rapidly rising incidence of type 2 diabetes and increasing healthcare investments

FUNDING This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), South Korea, funded by the Ministry of Education (NRF-2021R1A2C2008792)

Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial